FTFinancial Times·1hHealth
score+0.80
Moderna shares soar 60% on melanoma vaccine trial success
Original
Moderna shares soar 60% on melanoma vaccine trial success
“Strong positive market reaction to medical breakthrough, using active verbs like 'soar' to convey success.”